Top Markets
#1 Audiera Audiera +34.54%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.88%
#3 Bitcoin Cash Bitcoin Cash +32.85%
#4 GALA GALA +32.34%
#5 Fabric Protocol Fabric Protocol +32.09%
#6 Tutorial Tutorial +31.23%
#7 Zora Zora +27.86%
#8 B3 (Base) B3 (Base) +27.09%
#9 Talus Network Talus Network +26.49%
#10 Prom Prom +26.24%
Coin of the day
Audiera Audiera
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Clasificación en acciones #24646
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Precio por acción
$3.06
Capitalización bursátil
$58.25M
Cambio (1 día)
-0.65%
Cambio (1 año)
-73.27%
País
US
Comercio Elicio Therapeutics, Inc. (ELTX)

Categoría

Healthcare
Historial del precio de la acción de Elicio Therapeutics, Inc. (ELTX)
Precio más alto de cierre: $3.10 el 2026-08-01

Precio más bajo de cierre: $5.88 el 2023-11-01
Historial del precio de la acción de Elicio Therapeutics, Inc. desde 2023 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.38 37.72%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 58.85%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.47 435.74%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 9.84%
CH